Delivery Order SPE2DR25D9133-SPE2DR26FCFL9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,338.41 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of JAKAFI 20 mg tablets (60-count units). This firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of October 30, 2025, and does not utilize a set-aside designation. The award reflects DMS Pharmaceutical Group's competitive capability to...
- The Defense Logistics Agency awarded a delivery order valued at $24,793.16 to DMS Pharmaceutical Group Inc. for JAKAFI 5 mg tablets (60-count units) on November 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform work at its Park Ridge facility. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, allowing the vendor to compete on an unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $24,793.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for supply of JAKAFI 5 mg tablets (60-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The ultimate completion date is November 19, 2025, with...
- The Defense Logistics Agency awarded a $54,115.79 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of JAKAFI 10 mg. The award, issued on November 28, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, carries no set-aside designation, demonstrating the contractor's ability to compete effectively in unrestricted...
- The Defense Logistics Agency awarded a $258,404.76 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). The delivery order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. DMS Pharmaceutical Group Inc. is...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). This firm fixed-price delivery order was awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, and represents a routine pharmaceutical supply transaction without set-aside designation. The award was issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, was not set aside for any particular business category. DMS Pharmaceutical Group will perform under this order from...
- The Defense Logistics Agency has awarded a delivery order valued at $49.5K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of JAKAFI 5 MG. The award, issued on November 13, 2025, with an ultimate completion date of November 14, 2025, represents a firm fixed-price delivery order with no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the vendor's competitive capability in unrestricted...
- SPE2DR25D9133Indefinite Delivery Contract
- SPE2DR25D9133-SPE2DR26FCFL9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $36,739.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of JAKAFI 15 mg tablets (60-count units). The award, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in an unrestricted procurement environment. DMS Pharmaceutical Group will perform under its location in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents a component of the broader $30.3 billion acquisition strategy and authorizes DLA to issue delivery orders for comprehensive pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. The vendor's established performance on numerous prior delivery orders and its comprehensive product portfolio—spanning branded and generic prescription medications, biologics, and specialty pharmaceuticals—position it as a critical supplier within the federal military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.7k | 12/7/25 |